Fenglei Zhang

Person

Ambler, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,873,309
- Issue date Jan 16, 2024
- Incyte Corporation
- Kaijiong Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,613,536
- Issue date Mar 28, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 11,530,214
- Issue date Dec 20, 2022
- Incyte Holdings Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
- Patent number 11,472,791
- Issue date Oct 18, 2022
- Incyte Corporation
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,465,981
- Issue date Oct 11, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,407,749
- Issue date Aug 9, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 11,401,272
- Issue date Aug 2, 2022
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,339,149
- Issue date May 24, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 11,247,992
- Issue date Feb 15, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pi...
- Patent number 11,229,631
- Issue date Jan 25, 2022
- Incyte Corporation
- Chu-Biao Xue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 10,947,230
- Issue date Mar 16, 2021
- Incyte Corporation
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 10,800,779
- Issue date Oct 13, 2020
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 10,800,768
- Issue date Oct 13, 2020
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,717,737
- Issue date Jul 21, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 10,450,313
- Issue date Oct 22, 2019
- Incyte Holdings Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,300,051
- Issue date May 28, 2019
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aza spiro alkane derivatives as inhibitors of metalloproteases
- Patent number 10,226,459
- Issue date Mar 12, 2019
- Incyte Holdings Corporation
- Wenqing Yao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,174,030
- Issue date Jan 8, 2019
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 10,040,790
- Issue date Aug 7, 2018
- Incyte Holdings Corporation
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 9,944,647
- Issue date Apr 17, 2018
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AZA spiro alkane derivatives as inhibitors of metalloproteases
- Patent number 9,801,877
- Issue date Oct 31, 2017
- Incyte Corporation
- Wenqing Yao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 9,670,210
- Issue date Jun 6, 2017
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 9,533,984
- Issue date Jan 3, 2017
- Incyte Holdings Corporation
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 9,493,442
- Issue date Nov 15, 2016
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AZA spiro alkane derivatives as inhibitors of metalloproteases
- Patent number 9,403,775
- Issue date Aug 2, 2016
- Incyte Corporation
- Wenqing Yao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AZA spiro alkane derivatives as inhibitors of metalloproteases
- Patent number 8,637,497
- Issue date Jan 28, 2014
- Incyte Corporation
- Wenqing Yao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aza spiro alkane derivatives as inhibitors of metalloproteases
- Patent number 8,039,471
- Issue date Oct 18, 2011
- Incyte Corporation
- Wenqing Yao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aza spiro alkane derivatives as inhibitors of metalloproteases
- Patent number 7,723,349
- Issue date May 25, 2010
- Incyte Corporation
- Wenqing Yao
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRROLIDINE KRAS INHIBITORS
- Publication number 20240390340
- Publication date Nov 28, 2024
- INCYTE CORPORATION
- Onur ATASOYLU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20240368152
- Publication date Nov 7, 2024
- INCYTE CORPORATION
- Qinda YE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
- Publication number 20230226040
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Alejandro Amador Arjona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230226062
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230144051
- Publication date May 11, 2023
- INCYTE CORPORATION
- Qinda YE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220089588
- Publication date Mar 24, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20210395246
- Publication date Dec 23, 2021
- INCYTE CORPORATION
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210363137
- Publication date Nov 25, 2021
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210347771
- Publication date Nov 11, 2021
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210317139
- Publication date Oct 14, 2021
- INCYTE CORPORATION
- Kaijiong Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20210139485
- Publication date May 13, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210107900
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
- Publication number 20210032244
- Publication date Feb 4, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
- Publication number 20210024487
- Publication date Jan 28, 2021
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20210017156
- Publication date Jan 21, 2021
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PI...
- Publication number 20200405702
- Publication date Dec 31, 2020
- INCYTE CORPORATION
- Chu-Biao Xue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20200392143
- Publication date Dec 17, 2020
- INCYTE CORPORATION
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20200325115
- Publication date Oct 15, 2020
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20200172533
- Publication date Jun 4, 2020
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PI...
- Publication number 20200155527
- Publication date May 21, 2020
- INCYTE CORPORATION
- Chu-Biao Xue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20200095244
- Publication date Mar 26, 2020
- INCYTE CORPORATION
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20190292188
- Publication date Sep 26, 2019
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190225601
- Publication date Jul 25, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PI...
- Publication number 20190209537
- Publication date Jul 11, 2019
- INCYTE CORPORATION
- Chu-Biao Xue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
- Publication number 20190211014
- Publication date Jul 11, 2019
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190144439
- Publication date May 16, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
- Publication number 20190062301
- Publication date Feb 28, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY

Fenglei Zhang

Person

Patents Grantslast 30 patents

Heterocyclic compounds as immunomodulators

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Heterocyclic compounds as immunomodulators

Bicyclic heterocycles as FGFR inhibitors

Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors

Heterocyclic compounds as immunomodulators

Heterocyclic compounds as immunomodulators

Heterocyclic compounds as LSD1 inhibitors

Heterocyclic compounds as immunomodulators

Cyclopropylamines as LSD1 inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pi...

Bicyclic heterocycles as FGFR inhibitors

Heterocyclic compounds as LSD1 inhibitors

Heterocyclic compounds as immunomodulators

Cyclopropylamines as LSD1 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Cyclopropylamines as LSD1 inhibitors

Aza spiro alkane derivatives as inhibitors of metalloproteases

Cyclopropylamines as LSD1 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Heterocyclic compounds as LSD1 inhibitors

AZA spiro alkane derivatives as inhibitors of metalloproteases

Cyclopropylamines as LSD1 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Cyclopropylamines as LSD1 inhibitors

AZA spiro alkane derivatives as inhibitors of metalloproteases

AZA spiro alkane derivatives as inhibitors of metalloproteases

Aza spiro alkane derivatives as inhibitors of metalloproteases

Aza spiro alkane derivatives as inhibitors of metalloproteases

Patents Applicationslast 30 patents

PYRROLIDINE KRAS INHIBITORS

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS

THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PI...

HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PI...

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PI...

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

CYCLOPROPYLAMINES AS LSD1 INHIBITORS